Chemotherapy and Radiofrequency-Induced Mild Hyperthermia Combined Treatment of Orthotopic Pancreatic Ductal Adenocarcinoma Xenografts

Patients with pancreatic ductal adenocarcinomas (PDAC) have one of the poorest survival rates of all cancers. The main reason for this is related to the unique tumor stroma and poor vascularization of PDAC. As a consequence, chemotherapeutic drugs, such as nab-paclitaxel and gemcitabine, cannot effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Krzykawska-Serda, Martyna, Agha, Mahdi S., Ho, Jason Chak-Shing, Ware, Matthew J., Law, Justin J., Newton, Jared M., Nguyen, Lam, Curley, Steven A., Corr, Stuart J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054595/
https://www.ncbi.nlm.nih.gov/pubmed/29621664
http://dx.doi.org/10.1016/j.tranon.2018.02.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054595/
https://www.ncbi.nlm.nih.gov/pubmed/29621664
http://dx.doi.org/10.1016/j.tranon.2018.02.023

Ejemplares similares